PortfoliosLab logo

HUTCHMED China Ltd (0013.HK)

Equity · Currency in HKD · Last updated Jun 1, 2023

Company Info

ISINKYG4672N1198
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market CapHK$17.39B
EPSHK$0.00
PE RatioN/A
PEG RatioN/A
Revenue (TTM)HK$426.41M
Gross Profit (TTM)-HK$271.59M
EBITDA (TTM)-HK$399.03M
Year RangeHK$11.36 - HK$33.20

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in HUTCHMED China Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%2023FebruaryMarchAprilMay
-12.84%
1.41%
0013.HK (HUTCHMED China Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 0013.HK

HUTCHMED China Ltd

Return

HUTCHMED China Ltd had a return of -20.83% year-to-date (YTD) and 12.43% in the last 12 months. Over the past 10 years, HUTCHMED China Ltd had an annualized return of -46.09%, outperforming the S&P 500 benchmark which had an annualized return of -4.29%.


PeriodReturnBenchmark
1 month-19.49%-0.08%
Year-To-Date-20.83%6.77%
6 months-10.38%1.41%
1 year12.43%-3.48%
5 years (annualized)-46.09%-4.29%
10 years (annualized)-46.09%-4.29%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202320.00%-10.24%-20.12%16.46%
202262.50%11.89%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for HUTCHMED China Ltd (0013.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
0013.HK
HUTCHMED China Ltd
0.22
^GSPC
S&P 500
0.02

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current HUTCHMED China Ltd Sharpe ratio is 0.22. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.200.402023FebruaryMarchAprilMay
0.22
-0.02
0013.HK (HUTCHMED China Ltd)
Benchmark (^GSPC)

Dividend History


HUTCHMED China Ltd doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%2023FebruaryMarchAprilMay
-75.52%
-12.79%
0013.HK (HUTCHMED China Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the HUTCHMED China Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the HUTCHMED China Ltd is 84.85%, recorded on Oct 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.85%Jul 30, 2021305Oct 24, 2022
-15.14%Jul 23, 20213Jul 27, 20212Jul 29, 20215
-13.73%Jul 5, 20213Jul 7, 202110Jul 21, 202113

Volatility Chart

The current HUTCHMED China Ltd volatility is 12.80%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%2023FebruaryMarchAprilMay
12.80%
3.41%
0013.HK (HUTCHMED China Ltd)
Benchmark (^GSPC)